CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 19 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-15 | GORLIN STEVE Director | Sale | −26,835 | $4.13 | $111K | 494,885 |
| 2018-03-23 | Nelson Sonja Chief Accounting Officer | Option exercise | +15,000 | 15,000 | ||
| 2018-03-23 | Nelson Sonja Chief Accounting Officer | Option exercise · Restricted Stock Units | −15,000 | 15,000 | ||
| 2018-01-02 | Thomas John C Director | Gift | −4,500 | 274,155 | ||
| 2017-09-18 | DRISCOLL FREDERICK W Director | Grant or award | +54,621 | 54,621 | ||
| 2017-09-13 | GORLIN STEVE Director | Sale | −39,604 | $5.93 | $235K | 246,280 |
| 2017-09-12 | GORLIN STEVE Director | Sale | −35,811 | $6.03 | $216K | 285,884 |
| 2017-09-11 | GORLIN STEVE Director | Sale | −53,307 | $6.03 | $321K | 321,695 |
| 2017-09-08 | GORLIN STEVE Director | Sale | −14,723 | $6.12 | $90K | 375,002 |
| 2017-06-20 | Thomas John C Director | Sale | −10,000 | $7.43 | $74K | 308,655 |
| 2017-06-20 | Thomas John C Director | Sale | −20,000 | $7.44 | $149K | 288,655 |
| 2017-06-20 | Thomas John C Director | Sale | −10,000 | $7.54 | $75K | 278,655 |
| 2017-06-20 | GORLIN STEVE Director | Sale | −20,000 | $7.43 | $149K | 409,725 |
| 2017-06-20 | GORLIN STEVE Director | Sale | −20,000 | $8.13 | $163K | 389,725 |
| 2017-06-09 | Thomas John C Director | Grant or award | +23,753 | 318,655 | ||
| 2017-06-09 | POTTS JOHN T JR Director | Grant or award | +23,753 | 159,253 | ||
| 2017-06-09 | Kusserow Richard Director | Grant or award | +23,753 | 394,053 | ||
| 2017-06-09 | BLASZYK MICHAEL D Director | Grant or award | +23,753 | 73,753 | ||
| 2017-05-30 | Thomas John C Director | Gift | −12,500 | 294,902 | ||
| 2017-03-23 | Tajak Richard J. Chief Financial Officer | Option exercise | +5,000 | 14,859 |
Page 21 of 22 · 433 trades